Prosecution Insights
Last updated: April 19, 2026

Staidson (Beijing) Biopharmaceuticals Co. Ltd.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18165801 NERVE GROWTH FACTOR MUTANT BELYAVSKYI, MICHAIL A 1644 Non-Final OA Feb 07, 2023
17928136 ANTIBODIES SPECIFICALLY RECOGNIZING NERVE GROWTH FACTOR AND USES THEREOF KAUFMAN, CLAIRE M 1674 Non-Final OA Nov 28, 2022
17455880 NERVE GROWTH FACTOR MUTANT NIEBAUER, RONALD T 1658 Final Rejection Nov 19, 2021

Managing Staidson (Beijing) Biopharmaceuticals Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month